Global OTC Veterinary Drug Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Veterinary Drug Market Insights, Forecast to 2034
Over-the-counter (OTC) veterinary drugs are medications that can be purchased directly by pet owners without a prescription from a veterinarian. These medications are typically used for the treatment and management of minor health conditions in animals.
Market Analysis and InsightsGlobal OTC Veterinary Drug Market
Global OTC Veterinary Drug market is expected to reach to US$ 8800 million in 2024, with a positive growth of %, compared with US$ 8421 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, OTC Veterinary Drug industry is evaluated to reach US$ 13890 million in 2034. The CAGR will be 7.9% during 2024 to 2034.
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Report Covers
This report presents an overview of global OTC Veterinary Drug market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global OTC Veterinary Drug market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type
Oral
Injectable
Topical
Others
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, OTC Veterinary Drug introduction, etc. OTC Veterinary Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12QYResearch’s Conclusions of OTC Veterinary Drug
Chapter 13Methodology and Data Sources adopted by QYResearch
Market Analysis and InsightsGlobal OTC Veterinary Drug Market
Global OTC Veterinary Drug market is expected to reach to US$ 8800 million in 2024, with a positive growth of %, compared with US$ 8421 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, OTC Veterinary Drug industry is evaluated to reach US$ 13890 million in 2034. The CAGR will be 7.9% during 2024 to 2034.
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Report Covers
This report presents an overview of global OTC Veterinary Drug market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global OTC Veterinary Drug market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type
Oral
Injectable
Topical
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, OTC Veterinary Drug introduction, etc. OTC Veterinary Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12QYResearch’s Conclusions of OTC Veterinary Drug
Chapter 13Methodology and Data Sources adopted by QYResearch